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Abstract 
Growing number of clinical and experimental data reflect to the gender differences of 
hemorheological parameters. However, little is known about the potential hemorheological 
effect of gonadectomy and consequent changes in sex hormone concentration. Adult, same-
aged male and female rats were involved in the study. In control male and female group no 
surgical intervention was performed. In gonadectomized (GoE) male and female groups 
bilateral orchidectomy or ovariectomy were completed. Body weight measurement and blood 
sampling were carried out in the 1st, 2nd and 3rd postoperative months. The GoE females had 
significant bodyweight augmentation and their plasma estrogen concentration decreased by 
40-45% by the 1st postoperative month, while in males the testosterone level was not 
detectable after gonadectomy. Leukocyte and platelet counts moderately increased in GoE 
males. Elongation index values of erythrocytes slightly decreased in both genders after 
gonadectomy, showing converging values. Erythrocyte aggregation index values of GoE 
females significantly raised by the 2nd month. It can be concluded that gonadectomy in rats 
resulted in alteration (dominantly impairment) of blood micro-rheological parameters, by 
different manner in males and females. Supposedly decrease in estrogen can cause more 
expressed hemorheological changes than the cessation of testosterone. 
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1. Introduction 
Among the hemorheological parameters the factors representing the elongation, 
deformability of red blood cells or the reversible clamping of them, so aggregation are 
especially important because these factors have a major determinant role in the 
microcirculation [2,13,29,32,33,38]. These parameters show significant changes in various 
pathophysiological processes, diseases therefore the determination of them has a high value in 
surgical and microsurgical researches as well. 
 More and more clinical data reflect to the gender differences in the hemorheological 
parameters [4,12,15,22,41]. It is known, that in females blood viscosity, plasma viscosity, 
hematocrit and red blood cell aggregation have lower values and the red blood cell 
deformability parameters are better than in males [4,15]. However, in laboratory animals the 
rheological differences between females and males do not always correlate with the human 
pattern: the lower red blood cell aggregation values not obviously followed by better 
deformability parameters [17,28]. And all of this is additionally sophisticated with the inter-
species differences of the laboratory animals [25,44]. In research work all these data, the 
gender and inter-species differences have a great importance according to the planning of 
experiments, analyzing, evaluating as well as extrapolating the results. 
 However, the question may arise that what could be the hemorheological effect and 
the magnitude of changes caused by gonadectomy and how well it could be followed-up. Its 
clinical relevance is high and not only because of the physiological decreasing in gonadal 
function. Surgical orchidectomy or ovariectomy can be needed due to traumatization, laesion 
or more frequently because of tumors. 
Changes in gonadal function (caused by physiological or pathological reasons) may 
cause complex changes in many physiological parameters, including certain hematological 
variables (platelet- and leukocyte count) and affecting the coagulation parameters, the 
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complex neuroendocrin and immunological state, and even endothelial function 
[1,9,10,12,19,20,34]. However, little is known about the simultaneous changes of red blood 
cell aggregation and deformability after gonadectomy. 
In pilot studies we could observe changes in red blood cell deformability (tested by 
bulk filtrometry) 1-3 months after surgical gonadectomy in dogs and in rats [24,27]. For 
examining better this issue with devices that requires very small amount of blood samples, we 
aimed to perform a follow-up study in rats, investigating the effect of ovariectomy and 
orchidectomy on the red blood cell deformability (tested by ektacytometry) and red blood cell 
aggregation, together with hematological parameters and sex hormones. 
 
2. Materials and methods 
2.1. Experimental animals 
The experiments were approved and registered by the University of Debrecen 
Committee of Animal Research (permission Nr.: 37/2007), in accordance with the relevant 
Hungarian Animal Protection Act (Law XVIII/1998) and EU Directives (EEC 63/2010).  
Twenty adult, same-aged, healthy male (bodyweight: 455.16 ± 38.23 g) and sixteen 
female (bodyweight: 286.63 ± 13.32 g) Sprague-Dawley rats (Janvier Co., France) were 
involved in the study. 
In female animals the determination of actual estrus cycle phase was made by 
investigations of vaginal smear with Giemsa dying. The animals were in pro-estrus phase. 
 
2.2. Experimental groups, operative techniques and sampling protocol 
The following experimental groups were formed: 
Control males (n=10) and Control females (n=6): No surgical procedure was made, 
only blood samplings were performed. 
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Gonadectomy (GoE) males (n=10): under general anesthesia (60 mg/kg Thiopenthal®, 
i.p.) the scrotum was incised, both testes together with the epididymes were gently elevated, 
and after careful ligation of the ductus deferens and the vasculature bilateral orchidectomy 
was carried out. The scrotum incision was sutured (4/0 Dexon®). 
Gonadectomy (GoE) females (n=10): under general anesthesia (60 mg/kg 
Thiopenthal®, i.p.) a 1.5-2 cm long lower median laparotomy was carried out, the uterine 
tubes were identified till the ovariums. The ovaric arteries and veins were ligated together, as 
well as the upper third of the tuba, and the ovariectomy was made, bilaterally. The abdominal 
incision was sutured in two layers (4/0 Dexon®). 
After the operation and on the 1st postoperative day the animals received analgesics 
(Flunixin®, 2.5 mg/bwkg, s.c.). In the Control animals the same dosage was used, in parallel. 
Before operation (base) and on the 1st, 2nd and 3rd postoperative months –and in 
parallel in Control animals– body weight measurements and blood samplings were performed 
(0.6-0.8 ml per each) via puncture of the lateral tail vein. Sodium-EDTA (1.5 mg/ml) was 
used as anticoagulant. 
 
2.3. Laboratory investigations 
Hematological parameters were determined using a Sysmex F-800 microcell counter 
(TOA Medical Electronics Co., Ltd., Japan). In this study the white blood cell count (WBC 
[x103/µl]), monocyte-granulocyte and lymphocyte ratio (Mo-Gr%, Lymph%), red blood cell 
count (RBC [x106/µl]), hematocrit (Hct [%]), hemoglobin (Hgb [g/dl]), mean corpuscular 
volume (MCV [fl]), mean corpuscular hemoglobin (MCH [pg]), mean corpuscular 
hemoglobin concentration (MCHC [g/dl]) and platelet count (Plt [x103/µl]) were analyzed. A 
test requires approximately 70 µl of blood. 
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Red blood cell deformability was tested using a Rheoscan-D200 ektacytometer (Sewon 
Meditech Inc., Korea) [35]. For the measurements the red blood cell suspension was prepared 
in isotonic solution of polyvinylpyrrolidone (360 kDa, viscosity = 28.8 mPa.s; osmolarity = 
305 MOsm/kg; pH = 7.36), taking 6 µl of native blood into 0.6 ml PVP solution. The device 
creates a shear stress profile (~ 0.5 – 20 Pa) by a special slit-flow system using vacuum, 
where the elongating red blood cells alter the laser diffraction pattern. The elongation index 
(EI) at a constant shear stress (SS [Pa]) is calculated from the length (L) and width (W) of the 
diffractogram: EI = (L-W)/(L+W). EI increases with cell deformability [2]. For comparative 
parameterization of individual EI-SS curves Lineweaver-Burke analysis was used and the 
maximal elongation index (EImax) as well as the shear stress at half maximal deformation 
(SS1/2 [Pa]) values were calculated [3]. 
For testing red blood cell aggregation a Myrenne MA-1 erythrocyte aggregometer 
(Myrenne GmbH, Germany) was used. The device determines M (at 0 shear rate) and M1 (at 
shear rate of 3 s-1) indices, reflecting red blood cell aggregation according to the magnitude of 
light transmission at the 5th or 10th seconds of the aggregation process [33]. Both M and M1 
indices increase with enhanced red blood cell aggregation. The measurements require 
approximately 20 µl of blood. 
The hemorheological measurements (especially the aggregometry) were carried out 
within 1 hour after sampling, based upon the observation that rat red blood cell aggregation 
index may decrease by a highly significant manner over 2 hours after sampling [26]. 
The rest of the blood samples were centrifugated (at 2200G for 10 min). The 
determination of testosterone levels was based on electrochemiluminescence (ECL). 50 µl of 
plasma was incubated with Testosterone kit (ROCHE Diagnostics GMBH, Germany). For 
determining the estrogen levels, 35 µl plasma was required from each sample; Estradiol II kit 
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(ROCHE Diagnostics GMBH, Germany) was used for labeling. The measurements were 
performed by a Cobas E 411 analyzer (Hitachi High-Technologies Corporation, Japan). 
 
2.4. Statistical analyses 
Data are expressed as means and standard deviation (S.D.). Based on the normality of 
data distribution, for inter-group comparison Student t-test or Mann-Whitney RS test, for 
intra-group comparison (base and 1st, 2nd, 3rd months) one-way ANOVA tests (Bonferroni-
method) were used. The differences were accepted statistically significant at level of p<0.05. 
 
3. Results 
3.1. Bodyweight 
Figure 1 A,B shows the absolute and relative changes (versus base) of bodyweight in 
Control and Gonadectomized male and female animals. 
Comparing to the continuously increasing bodyweight of Control males, the Control 
females did not show remarkable changes over the 3-month follow-up period, keeping the 
well-visible gender differences (p<0.001). Bodyweight augmentation of GoE males was 
sustained over the 2nd postoperative month, but still keeping the significant difference 
compared to females. By the 3rd month the difference between Control and GoE males was 
significant (p=0.036). In GoE females obvious and significant augmentation in bodyweight 
was observed by the 1st postoperative month (from 286.5 ± 16.2 to 358.6 ± 61.7 g; p<0.001), 
and showing further increase gradually. The increase significantly exceeded the data of 
Control females (p=0.032; p=0.01; p=0.011, respectively on 1st,2nd and 3rd month) (Fig. 1A).  
The relative bodyweight data (relative value versus base) markedly showed the 
differences between groups. Control females did not expressed significant changes over the 3-
month period, while Control males showed mild increase, and reaching the significance level 
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only by the 3rd month (1.25 ± 0.12; p=0.024). The largest augmentation was shown by the 
GoE female group (1st month: 1.22 ±0.19; 2nd month: 1.29 ± 0.23; 3rd month: 1.32 ± 0.21), 
which was significant versus base (p=0.001), versus Control females (p=0.011; p=0.016; 
p=0.011, respectively) and compared to GoE males, too (p=0.038; p=0.007; p=0.004, 
respectively).  In GoE males the relative values were similar to Control females (Fig. 1B). 
 
3.2. Estrogen and testosterone concentration 
The base level of plasma estrogen concentration (E2) was 24.79 ± 15.7 pg/ml. By one 
month after ovariectomy the E2 concentration decreased by only about 40-45% (1st month: 
13.9 ± 2.34 pg/ml; 2nd month: 16 ± 2.4 pg/ml; 3rd month: 14.8 ± 5.1 pg/ml, representing 
56.4%, 64.6% and 59.7% of the base level, respectively) (Fig. 2A). 
After orchidectomy, the initial 8.56 ± 3.67 nmol/l testosterone plasma concentration 
has been fallen under the level of detectability (<0.069 nmol/l) (Fig. 2B).  
 
3.3. Hematological parameters 
White blood cell (WBC) count significantly increased by the 1st postoperative month 
in both operated (GoE) groups. The increase was significant versus base (p=0.006) and 
compared to the Control animals (p<0.001). In the 2nd month the values of GoE males were 
similar to Controls, while GoE females expressed moderately elevated WBC count (p=0.049 
vs Control). By the 3rd postoperative month in GoE males the WBC count increased again  
(p=0.002 versus control, p=0.012 versus GoE females) (Fig. 3A). The monocyte-granulocyte 
ratio was the highest in the 1st postoperative month (30-35%), then decreased in all groups, 
without marked difference. 
The red blood cell (RBC) count was higher in males independently of the 
orchidectomy. However, a slight decrease in RBC count could have been observed in GoE 
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males during the 2nd and 3rd month compared to those increased values in the 1st postoperative 
month (Fig. 3B).  
A hematocrit values have been changed in parallel with the RBC count. However, 
significant difference was seen only in GoE males versus GoE females in the 1st postoperative 
month and versus Control males in the 2nd month (p=0.021, p=0.019, respectively) (Fig. 3C). 
The platelet (Plt) count was higher in males, which difference was significantly 
enlarged in GoE males in the 1st and 3rd postoperative months compared to base (p=0.022 and 
p=0.007, respectively) and versus GoE female group (p<0.001 and p=0.005, respectively) 
(Fig. 3D). The other hematological parameters did not show important differences.  
 
3.4. Red blood cell deformability 
Figure 4 (A-H) shows the elongation index (EI) – shear stress (SS) cumulative curves 
in all groups during the follow-up period. The comparative data and calculated parameters 
(EImax and SS1/2) are presented in Table I. 
Before operations gender differences could be seen: in females the EI values were 
higher (at 5 Pa p=0.014, at 10 Pa: p=0.002 in Controls). In Control groups these differences 
were well observable over the follow-up period. In GoE groups the EI data of male and 
female animals slightly changed, converging to each other (Fig. 4).  
In GoE males and females the EI at 3 Pa moderately increased by the 1st postoperative 
month (p=0.002 and p=0.004 versus base, respectively) and remained elevated (2nd month: in 
males p=0.002 versus base, in females 0.001 versus Control; 3rd month: in males p<0.001 
versus base, in females p=0.019 versus base), while in Controls only the males showed an 
undulation in EI values (Table I).  
At 5 or 10 Pa the control animals did not expressed important changes, while in GoE 
animals the increase in EI was significant: by the 1st postoperative month in GoE males and 
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females versus base values (at 5 Pa p=0.003 and p=0.002, at 10 Pa p=0.037 and p=0.0106, 
respectively). There was significant difference between GoE male and females groups, too: at 
5 Pa p=0.009, at 10 Pa p=0.019. 
By the 2nd postoperative month EI values of GoE groups slightly decreased and 
moderately augmented again by the 3rd month, showing significant difference compared to its 
base values (at 5 Pa: p<0.001 in GoE males and p=0.003 in GoE females). Remarkable, that 
in the 2nd postoperative month the comparative EI values of both GoE groups at 3, 5 or 10 Pa 
significantly were fallen short of Control values (at 3 Pa p=0.001 in males; at 5 Pa: p=0.007 
and p=0.005, at 10 Pa: p=0.005 and p=0.002 in males and females respectively). 
In Control and tendentiously in GoE males the EImax values calculated from individual 
EI-SS curves slightly decreased in the 2nd and 3rd postoperative months. The initially visible 
gender difference in SS1/2 disappeared over the follow-up period. In GoE males the decrease 
in SS1/2 was marked by the 1st month (p<0.001 versus base) (Table I). 
 
3.5. Red blood cell aggregation 
Figure 5 shows M and M1 aggregation index values (at both 5 and 10 secundum) 
tested in samples taken in the 2nd and 3rd postoperative months. 
In Control animals aggregation index values were higher in males. In 2nd postoperative 
month the GoE males showed slightly elevated index values but not as much as it could be 
seen in GoE female groups, where the rise in aggregation index values was remarkable. All 
index values showed significant difference compared to Control animals (5 sec M: p=0.003, 5 
sec M1 and 10 sec M: p<0.001, 10 sec M1: p=0.002) and also versus GoE males at 10 sec 
values (M: p<0.001, M1: p=0.002) (Fig. 5A). 
That marked rise in GoE females could not be observed in the 3rd postoperative month, 
rather a kind of converging of GoE group values was seen. However, the 10 sec M and M1 
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values of GoE female group were still significantly higher compared to Control females 
(p=0.034 and p<0.001, respectively) (Fig. 5B).  
 
4. Discussion 
Numerous population or epidemiological studies report hemorheological alterations in 
cardiovascular diseases with or without influencing by the gender [6,14,15,16,18,36,43,45]. 
However, in both clinical and experimental studies increasing data on hemorheological 
gender differences raise several questions regarding the background. The red blood cell 
deformability and red blood cell aggregation parameters show obvious gender differences in 
laboratory animals, too, complicated with inter-species differences [17,25,28,44]. While in 
human the men express higher aggregation index values and ’decreased’ red blood cell 
deformability [4,15], in rats the females show better red blood cell deformability values with 
higher aggregation index [28]. However, hemorheological consequences of decreased gonadal 
function (caused by physiological, pathological processes or exogen noxa) are still 
controversial and has not been completely clarified, yet [37,39,42]. 
In our study we aimed to follow-up the hemorheological effects of gonadectomy in 
male and female rats using same-aged control animals. The main findings were the 
followings: (1) The gonadectomised females had the most expressed augmentation in 
bodyweight, (2) their plasma estrogen concentration (E2) decreased only by 40-45% by the 1st 
postoperative month, while in males the testosterone level was not detectable after 
gonadectomy. (3) Hematological parameters did not show specific changes, however, 
moderately increased white blood cell and platelet counts were observed in gonadectomised 
males. (4) Elongation index values of red blood cells slightly decreased in both genders after 
gonadectomy, showing converging values by the 2nd and 3rd postoperative months. (5) Red 
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blood cell aggregation index values of gonadectomised females significantly raised by the 2nd 
postoperative month, which elevation was not observable in the 3rd month. 
The hemorheological parameters can be altered by many factors in vivo, therefore the 
explanation of the effect of gender and sex hormones non red blood cell micro-rheological 
properties is quite complex and has not been clarified, yet.  
Concerning the estrus cycle, in the current study all female animals were in the same 
cycle-phase: in pro-estrous (according to the investigations of vaginal smear with Giemsa 
dying). Since human data presented that hemorheological parameters can be varied during the 
menstrual cycle because of the sex-hormone level changes [11,30], it would be interesting to 
investigate this question in laboratory animals, too, following-up the variable through the 
other phases of the cycle (estrous, met-estrous, di-estrous). Machiedo et al. [21] investigated 
the trauma-hemorrhagic shock in female rats at different stages of the estrous cycle, besides 
male animals, and found significant differences of red blood cell morphological and 
deformability parameters according to the estrous cycle. Male rats and females in met-estrous 
or di-estrous had significantly higher percentage of abnormal red blood cells immediately 
after the shock and during the resuscitation period [21]. It is supposed that the difference we 
found between male and females rats in pro-estrous may differ during the estrous cycle. 
In previous animal experiments gonadectomy as well as sex-hormone substitution had 
effect on hemorheological variables [24,27,31]. In rats ovariectomy was shown to increase 
hematocrit, fibrinogen concentration, red blood cell aggregation and blood viscosity [31]. 
However, the magnitude of these changes in laboratory animals is still not revealed 
completely, yet. Long-term follow-up studies are needed for investigating whether the 
hemorheological parameters can show various alterations during the postoperative months in 
gonadectomized male or female animals [27]. In the current study we used a 3-month period 
for follow-up, which is considered a relatively long-term period in case of the rat. 
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The question of hormone substitution is quite complex being still controversial 
concerning the potential effects of sex-hormones on hematological, hemostaseological and 
hemorheological variables. However, the administration of estrogen (as estrogen replacement) 
may have a protective effect against ischemic injury, it increases the risk of thrombotic 
complications both in women and even in men [10,19,20,39,41,42]. Spengler and co-workers 
demonstrated that in menopausal women hormone replacement therapy resulted in 
ameliorating hemorheological parameters over 6-month of therapy. They observed diminution 
in blood viscosity and erythrocyte rigidity, as well as decrease in fibrinogen concentration and 
erythrocyte aggregation [37]. 
In animal experiments this question has also been studied, however, the 
hemorheological data are diverse. In a previous mongrel dog study gonadectomy and reverse 
sex-hormone substitution protocols were used [7], where after gonadectomy estrogen for 
males and testosterone for females were administrated for a month. Besides cardiac effect [7], 
interesting hemorheological effects were observed: one month after gonadectomy filtration of 
red blood cell suspension worsened (RCTT increased) in both genders but expressed more in 
males. After a 1-month cross-sex hormone administration the RCTT improved in both 
genders, and in males hematocrit and blood viscosity decreased [24]. 
Growing number of studies show that various hormones (sex hormones, stress 
hormones) have direct or indirect effects on red blood cell aggregation or deformability 
[5,8,40]. However, the direct effect of sex-hormones on the red blood cells is still disputed. 
For evaluation and comparison of the results it is important to note that the investigative 
methods are different in the laboratories.  
The in vitro preparations, type of buffers and vehicle molecules of the media in what 
the red blood cells are suspended, all may influence the results. Since sex-hormones are 
steroid-like molecules, their administration needs lipid-like carrier in the buffer that also 
 13
determines the results of the control investigations, too [23, unpublished observations]. 
Therefore this issue needs more studies to clarify the potential direct effect of sex hormones 
on red blood cells’ rheological properties. 
 
5. Conclusions 
There are marked and sometimes controversially data available in the literature on 
gender differences in hemorheological parameters in human and in animals, that differences 
can be supposedly modulated by changes in gonadal function. In this study it could be 
observed that gonadectomy in rats resulted in alteration (dominantly impairment) in blood 
micro-rheological parameters during the first 3 postoperative months. The alterations were of 
different manner in males and females. Data suggested that a decrease in estrogen (E2) can 
cause more expressed increase in red blood cell aggregation and moderate impairment in red 
blood cell deformability than the cessation of testosterone.  
Various effects of induced processes in male and female animals raise further aspects 
of comparisons and so the altered hormonal states need more studies to clarify better the 
complex hemorheological changes in follow-up studies. These observations may be 
interesting for veterinary medicine, too.  
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8. Tables 
 
Table 1.  Changes of parameters describing red blood cell deformability in Control and 
Gonadectomized (GoE) male and female animals. 
 
Variable Group Gender Base Postoperative month 
1st 2nd 3rd  
EI at 3 Pa Control Male 0.328 ± 0.018 0.340 ± 0.016  0.350 ± 0.011*# 0.331 ± 0.015 # 
Female 0.350 ± 0.007 0.345 ± 0.009 0.360 ± 0.012 0.345 ± 0.008 
GoE Male 0.317 ± 0.02 0.336 ± 0.015 * 0.336 ± 0.021 * 0.339 ± 0.016 * 
Female 0.327 ± 0.02 0.345 ± 0.014 * 0.335 ± 0.021 + 0.342 ± 0.011 * 
EI at 5 Pa Control Male 0.399 ± 0.001 # 0.401 ± 0.012 0.403 ± 0.015 0.398 ± 0.013 # 
Female 0.408 ± 0.005 0.404 ± 0.008 0.412 ± 0.009 0.410 ± 0.012 
GoE Male 0.381 ± 0.015 # 0.396 ± 0.013*# 0.388 ± 0.019 + 0.403 ± 0.011 * 
Female 0.391 ± 0.016 0.407 ± 0.013 * 0.394 ± 0.018 + 0.407 ± 0.011 * 
EI at 10 Pa Control Male 0.463 ± 0.01 # 0.462 ± 0.012 0.465 ± 0.011 # 0.459 ± 0.009 # 
Female 0.476 ± 0.006 0.470 ± 0.009 0.477 ± 0.012 0.470 ± 0.007 
GoE Male 0.451 ± 0.014 0.461 ± 0.012*# 0.453 ± 0.014 + 0.460 ± 0.01 # 
Female 0.457 ± 0.015 0.470 ± 0.013 * 0.457 ± 0.017 + 0.467 ± 0.008 
EImax Control Male 0.595 ± 0.018 0.590 ± 0.022 0.566 ± 0.013*# 0.573 ± 0.011*# 
Female 0.602 ± 0.028 0.586 ± 0.015 0.586 ± 0.012 0.585 ± 0.012 
GoE Male 0.589 ± 0.028 0.576 ± 0.018 + 0.561 ± 0.017*# 0.572 ± 0.02 * 
Female 0.578 ± 0.023 0.585 ± 0.015 0.579 ± 0.03 + 0.581± 0.023 
SS1/2 [Pa] Control Male 2.65 ± 0.32 # 2.48 ± 0.45 2.04 ± 0.18 * 2.32 ± 0.25 * 
Female 2.45 ± 0.49 2.29 ± 0.35 2.14 ± 0.24 2.24 ± 0.17 
GoE Male 2.84 ± 0.54 # 2.33 ± 0.4 * 2.24 ± 0.48 * 2.22 ± 0.37 * 
Female 2.49 ± 0.4 2.25 ± 0.37 2.43 ± 0.6 2.23 ± 0.41 
* p<0.05 vs Base,  # vs Female;  + vs Control  
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9. Figure captions 
 
Figure 1. 
Absolute (A) and relative bodyweight values (versus base) (B) in control and gonadectomized 
(GoE) male and female animals before operation and 1-3 months after gonadectomy. 
means ± S.D., * p<0.05 vs Base,  # vs Female;  + vs Control  
 
Figure 2. 
Base values and postoperative changes in plasma concentration of estrogen [pg/ml] (A) and 
testosterone [nmol/l] (B) in gonadectomized female and male animals. 
means ± S.D. 
 
Figure 3. 
White blood cell count (WBC [x103/µl]) (A), red blood cell count (RBC [x106/µl]) (B), 
hematocrit, (Hct [%]) (C) and platelet count (Plt [x103/µl]) (D) in control and gonadectomized 
(GoE) male and female animals before operation and 1-3 months after gonadectomy. 
means ± S.D., * p<0.05 vs Base,  # vs Female;  + vs Control  
 
Figure 4. 
Elongation index (EI) values of base and postoperative samples (1st, 2nd, 3rd month) in the 
function of shear stress (SS [Pa]) in control (A-D) and gonadectomized (GoE) male and 
female animals (E-H). 
means ± S.D. 
 
Figure 5. 
Aggregation index M and M1 values at 5 and 10 secundum mode tested on 2nd (A) and 3rd 
postoperative month (B).  
means ± S.D., # p<0.05 vs Female;  + vs Control  
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